Funding opportunities
Open and upcoming programs from Canadian funders and US federal grants (Grants.gov). Deadlines first, then rolling intakes.
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
National Institutes of Health · Deadline not published
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). The IBDGC has led collaborative efforts resulting in the identification of >300 genetic risk loci for different IBD subtypes across patient populations and characterization of underlying biological mechanisms. Despite advances in biological understanding and the development of a range of biologic therapies, IBD remains a chronic, severe and heterogenous disease with no cure requiring multiple interventions over the life course. Diagnostic biomarkers and accurate predictors of critical outcomes including disease remission, recurrence, and response to specific therapies are lacking. The IBDGC will leverage patient cohorts, biospecimens and advances in data science to characterize the interactions of genetic, clinical and environmental factors in disease development and progression, and to develop new predictors of disease outcomes, with the goal of improving medical management and advancing precision medicine for IBD patients. The IBDGC may include up to 7 Genomic Research Centers with varying rese
The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center
National Institutes of Health · Deadline not published
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). The IBDGC has led collaborative efforts resulting in the identification of >300 genetic risk loci for different IBD subtypes across patient populations and characterization of underlying biological mechanisms. Despite advances in biological understanding and the development of a range of biologic therapies, IBD remains a chronic, severe and heterogenous disease with no cure requiring multiple interventions over the life course. Diagnostic biomarkers and accurate predictors of critical outcomes including disease remission, recurrence, and response to specific therapies are lacking. The IBDGC will leverage patient cohorts, biospecimens and advances in data science to characterize the interactions of genetic, clinical and environmental factors in disease development and progression, and to develop new predictors of disease outcomes, with the goal of improving medical management and advancing precision medicine for IBD patients. The Data Coordinating Center (DCC) of the IBDGC will coordinate collabor
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
National Institutes of Health · Deadline not published
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the work of the NIDDK Gastroparesis Consortium (GpCRC) but also to expand its scope. The collaborative efforts of the GpCRC provided a large database, the Gastroparesis Registry, which is located in the NIDDK central repository and contains information on patients with symptoms of either delayed or normal gastric emptying. It also houses the first U.S. registry of children and adolescents with gastroparesis. The GpCRC provided clarity and insight that set the stage for transforming our understanding of gastroparesis and laid out a road map for approaching other disorders of gastrointestinal (GI) motility. The findings from clinical studies and trials clearly demonstrated that the clinical burden of gastroparesis is significantly greater than previously realized and involves much more than the stomach. Importantly, the underlying mechanisms remain unclear. Interoception is the ability of the nervous system to sense, interpret and coordinate signals from various bodily systems including the GI tract. Many functional GI disorders are associated with a spectrum of
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
National Institutes of Health · Deadline not published
The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the work of the NIDDK Gastroparesis Consortium (GpCRC) but also to expand its scope. The collaborative efforts of the GpCRC provided a large database, the Gastroparesis Registry, which is located in the NIDDK central repository and contains information on patients with symptoms of either delayed or normal gastric emptying. It also houses the first U.S. registry of children and adolescents with gastroparesis. The GpCRC provided clarity and insight that set the stage for transforming our understanding of gastroparesis and laid out a road map for approaching other disorders of gastrointestinal (GI) motility. The findings from clinical studies and trials clearly demonstrated that the clinical burden of gastroparesis is significantly greater than previously realized and involves much more than the stomach. Importantly, the underlying mechanisms remain unclear. Interoception is the ability of the nervous system to sense, interpret and coordinate signals from various bodily systems including the gastrointestinal tract. Many functional GI disorders are associated with
The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)
National Institutes of Health · Deadline not published
The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to develop, operate, and sustain a cloud-based data storage and computing platform that democratizes access to large-scale Alzheimer’s disease (AD) and AD-related dementias (ADRD) genetic and genomic data. The platform must be secure, scalable, and interoperable. The platform will support the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS), the primary NIA-supported repository for the archiving and distribution of human genetic data related to AD/ADRD. The purpose of the platform will be to: Enable efficient ingestion, curation, harmonization, and analysis of multi-ancestry, large population-scale datasets; Provide robust analysis, visualization, and artificial intelligence -ready resources within secure cloud workspaces; Ensure compliance with federal security and data-sharing policies; Promote interoperability with other NIH- and NIA-supported repositories; and Provide user support, training, and community engagement. The NOFO aims to foster collaboration, accelerate discovery, and maximize the scientific value and impact of AD/ADRD genetics rese
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
National Institutes of Health · Deadline 2026-11-02
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
National Institutes of Health · Deadline 2026-11-02
This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
National Indian Health Outreach and Education
Indian Health Service · Deadline 2026-11-02
The purpose of this NOFO is to further the IHS mission and goals related to providing quality health care to the AI/AN community through outreach and education. Our focus is on promoting awareness, visibility, training, technical assistance, and education in the following components:Health education and outreach.Rural Health Transformation review and outreach and education on the Indian Health Care Improvement Act.Substance abuse and suicide prevention.Domestic violence prevention.Special diabetes program for American Indians.Tribal budget formulation activities.Tribal youth health advisory activities. Awards range from $246,311 to $1,101,311.
Autism Centers of Excellence R01
National Institutes of Health · Deadline not published
The Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD), with the National Institute on Deafness and Other Communication Disorders ( NIDCD ), National Institute of Environmental Health Sciences ( NIEHS ), National Institute of Mental Health ( NIMH ), and National Institute of Neurological Disorders and Stroke ( NINDS ), intends to publish a Notice of Funding Opportunity (NOFO) for the Autism Centers of Excellence (ACE) Network to solicit applications for research that will build on the progress and momentum of the past 23 years of ACE research and that takes advantage of cutting-edge technologies and methods. The ACE network has used R01 funding mechanism to allow multisite collaborations since the beginning of the ACE program in 2007. Each ACE Network will consist of a multi-site project focusing on a specific topic of research for R01 support through this FOA. Each ACE Network will submit one R01 application that includes sub-awards to the collaborating sites. Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive project
Autism Centers of Excellence P50
National Institutes of Health · Deadline not published
The Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD), with the National Institute on Deafness and Other Communication Disorders ( NIDCD ), National Institute of Environmental Health Sciences ( NIEHS ), National Institute of Mental Health ( NIMH ), and National Institute of Neurological Disorders and Stroke ( NINDS ), intends to publish a Notice of Funding Opportunity (NOFO) for the Autism Centers of Excellence (ACE) to solicit applications for research that will build on the progress and momentum of the past 23 years of ACE research and that takes advantage of cutting-edge technologies and methods. Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the P50 - Research Program Projects and Centers activity code. Investigators with expertise and insights into this area of research are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in scientific disciplines will be encouraged, and these investigators should also be
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
National Institutes of Health · Deadline not published
This notice of funding opportunity (NOFO) invites grant applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of support for cancer research career continuity.
FAIR HOUSING INITIATIVES PROGRAM PRIVATE ENFORCEMENT INITIATIVE
Department of Housing and Urban Development · Deadline 2026-11-02
Congress amended the Fair Housing Act in 1988 to establish the Fair Housing Initiatives Program (FHIP) to provide funding to entities to work alongside HUD to "prevent or eliminate discriminatory housing practices" 42 USC §3616a (a). Congress determined in 1987, and has affirmed each year since then through appropriations, that HUD can only achieve its fair housing mission and obligations through supporting a network of organizations helping to educate the public and enforce fair housing rights. Initially a demonstration program, Congress made FHIP permanent in 1992 through the Housing and Community Development Act of 1992. The program was expanded in 1992 to address building capacity in unserved areas, establish a national media campaign, and fund a National Fair Housing Month.FHIP provides funds to eligible organizations through competitive grants under four initiatives: the Fair Housing Organizations Initiative (FHOI), the Private Enforcement Initiative (PEI), the Administrative Enforcement Initiative (AEI), and the Education and Outreach Initiative (EOI).This NOFO funds the PEI to provide grants to a nationwide network of eligible private, non-profit fair housing enforcement or Awards range from $500,000 to $1,500,000.
Fair Housing Initiatives Program - Education and Outreach Initiative
Department of Housing and Urban Development · Deadline 2026-11-02
Congress in 1988 established the Fair Housing Initiatives Program (FHIP) with a purpose of providing funding to entities to work alongside HUD to "prevent or eliminate discriminatory housing practices" 42 USC § 3616a(a). FHIP provides funds to eligible organizations through competitive grants. under several initiatives.The overarching purpose of the FHIP Education and Outreach Initiative (EOI) is to educate the public, housing providers and other stakeholders about their rights and obligations under provisions of fair housing laws, through the development, implementation, carrying out and coordinating or education and outreach programs. 42 USC § 3616a(d)(1); 24 CFR 125.301(a).The National Media Campaign component (EOI-NMC) is "designed to provide a centralized, coordinated effort for the development and dissemination of fair housing media products." 42 USC § 3616a(d)(1). A portion of NMC funds are specifically meant to increase participation in the annual national fair housing month. Under a cooperative agreement, HUD will exercise the right to approve, and have substantial involvement in, all proposed deliverables, as well as the Work Plan or Statement of Work (SOW).The General Co Awards range from $175,000 to $2,500,000.
AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)
Health Resources and Services Administration · Deadline not published
The purpose of this program is to provide funding to states/territories to prevent, reduce, or eliminate ADAP waiting lists or to address other ADAP shortfalls. Awards up to $10,000,000.
Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
Centers for Disease Control and Prevention - ERA · Deadline not published
The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data. Examples of biospecimens include fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Demographic data includes age, sex, race, and occupational history. Clinical data includes stage, treatment, and survival information. The virtual registry and tissue bank also serve as a virtual repository and offer a library of biospecimens and data that investigators can use and share, including genomic, transcriptomic, and proteomic data. The NMVB can: Help identify early signs of disease. Support the development of biomarkers that show disease stage and prognosis. Help develop new or improved treatment options. The goal is to continue to expand the NMVB and improve its ability to be a resource for both biomedical researchers and the clinical science community focused on malignant mesothelioma research. Awards range from $750,000 to $1,100,000.
Tribal Colleges Extension Program Special Emphasis
National Institute of Food and Agriculture · Deadline 2026-11-02
The TCEP-SE under assistance listing 10.517, provides informal, community-focused extension pilot projects at 1994 Institutions. Pilot projects may focus on community needs that address emerging issues such as agricultural productivity, improving food systems, community vitality, workforce and economic development, public health and well-being, engaging Tribal youths, and preparing the next generation of Tribal agriculture leaders. Awards range from $50,000 to $200,000.
Emergency Citrus Disease Research and Extension Pre-Applications
National Institute of Food and Agriculture · Deadline 2026-11-02
In FY 2026, the ECDRE program, under Assistance Listing 10.309, is soliciting proposals to develop effective tactics and strategies to control HLB and its disease complex for financially sustainable citrus production in the United States. All projects funded by the ECDRE program will incorporate collaborative approaches that integrate available knowledge to develop new solutions that can be deployed by growers to manage and prevent HLB infection in the near term. Awards range from $500,000 to $15,000,000.
BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)
Bureau of Justice Assistance · Deadline 2026-11-02
This is a notice of funding opportunity (NOFO) for the Comprehensive Opioid Stimulant and Substance Use Program (COSSUP) Training and Technical Assistance (TTA). This opportunity will provide training and technical assistance to BJA COSSUP grantees to address technical operational challenges to improve responses to overdose deaths, illicit opioids, stimulants, and other substances. Awards up to $2,000,000.
BJA FY 2026 Upholding the Rule of Law and Preventing Wrongful Convictions Program
Bureau of Justice Assistance · Deadline 2026-11-02
This is a notice of funding opportunity (NOFO) for the BJA FY 2026 Upholding the Rule of Law and Preventing Wrongful Convictions Program. This opportunity strengthens the capacity of wrongful conviction review (WCR) entities and their criminal justice and victims’ services partners to more effectively and efficiently identify, assess, and manage post-conviction claims of innocence. Additionally, it aims to enhance public safety by preventing future errors, identifying actual perpetrators of crimes, and delivering justice to victims. Awards up to $600,000.
OJJDP FY 2026 Second Chance Act Youth Reentry Program
Office of Juvenile Justice Delinquency Prevention · Deadline 2026-11-02
This is a notice of funding opportunity (NOFO) for the OJJDP FY 2026 Second Chance Act Youth Reentry Program. This opportunity will support states, units of local government, federally recognized Native American Tribal governments, and community-based organizations to provide (1) comprehensive reentry services for moderate- to high-risk youth before, during, and after release from confinement, and (2) support transitional services to assist youth to successfully reenter the community. This program supports collaborations between state agencies, local government, Tribes, and community- and faith-based organizations to address the challenges that reentry and recidivism reduction pose for moderate to high-risk juvenile offenders returning to their communities from juvenile residential or correctional facilities. Awards up to $750,000.